Faculty profile

Mark Ruschin

ResearcherRadiation OncologyUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Mark Ruschin

Researcher

Radiation Oncology

Natural Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
40 publications in the last five years, latest in 2026.
Senior (last) author on 7 recent papers, a sign of leading a research group.
Principal investigator on 1 research grant (1 NSERC), most recently in 2019.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

120

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

artificial intelligence automation decision support machine learning optimization outcomes radiosurgery treatment planning

Latest papers

Outcomes following stereotactic body radiation therapy specific to spinal metastases with paraspinal disease extension: does volume matter?
Journal of Neurosurgery: Spine · 2026
MRI-guided adaptive radiotherapy for high grade glioma (UNITED): a single-centre, single-arm, non-inferiority, phase 2 trial
The Lancet Oncology · 2026
Impact of Adherence to Target Volume Contouring Guidelines on Patterns of Failure in Sacral Stereotactic Body Radiotherapy
Practical Radiation Oncology · 2026

All 96 publications

Latest funding

MR-Linac guided adaptive radiotherapy in glioblastoma multiforme
CIHR · 2020 · Co-investigator
$558,450
Decision Support System for Stereotactic Radiosurgery
NSERC · 2019 · Principal investigator
$144,000
Development of a magnetic resonance imaging and image-analysis framework for high-precision gamma knife-based stereotactic radiosurgery of brain tumours
NSERC · 2016 · Co-investigator
$391,859

All 3 grants and awards

96 publications.

Outcomes following stereotactic body radiation therapy specific to spinal metastases with paraspinal disease extension: does volume matter?

Ong WL, Zeng KL, Moore-Palhares D, Soliman H, Myrehaug S, Detsky J, Chen H, Ruschin M, Atenafu EG, Larouche J

Journal of Neurosurgery: Spine20266 citations

DOI: 10.3171/2025.6.spine25376

MRI-guided adaptive radiotherapy for high grade glioma (UNITED): a single-centre, single-arm, non-inferiority, phase 2 trial

Detsky JS, Chan AW, Moore-Palhares D, Safavi AH, Perry J, Fat MJL, Atenafu EG, Das S, Lipsman N, Heyn C

The Lancet Oncology20262 citations

DOI: 10.1016/s1470-2045(26)00088-4

Impact of Adherence to Target Volume Contouring Guidelines on Patterns of Failure in Sacral Stereotactic Body Radiotherapy

Moore-Palhares D, Zeng KL, Tseng C-L, Chen H, Soliman H, Dinakaran D, Maralani P, Ruschin M, Zhang B, Sahgal A

Practical Radiation Oncology2026

DOI: 10.1016/j.prro.2026.07.001

Influence of FLAIR inclusion on patterns-of-failure and outcomes in glioblastoma: results from the UNITED prospective adaptive radiotherapy trial.

Ghosh S, Stewart J, Ruschin M, Chen H, Tseng CL, Soliman H, Sahgal A, Detsky J

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2026

DOI: 10.1016/j.radonc.2026.111579 PMID: 42142536

First Report of Staged Adaptive Frameless Stereotactic Radiosurgery in 3 "Pulses" to Salvage Brain Metastases that Failed Previous Radiosurgery.

Tong D, Shor D, Zhang B, Ruschin M, Detsky JS, Dinakaran D, Soliman H, Tseng CL, da Costa L, Das S, Heyn C, Holden L, Atenafu EG, Sahgal A, Chen H

Neurosurgery2026

DOI: 10.1227/neu.0000000000004142 PMID: 42340322

Gamma knife knowledge-based planning with isocenter selection.

Zhang B, Ruschin M, Chan TCY

Medical physics2026

DOI: 10.1002/mp.70463 PMID: 42135596

The transformative role of SBRT in the management of spinal metastases.

Zeng KL, Maralani PJ, Hardisty M, Chen H, Detsky J, Dinakaran D, Soliman H, Tseng CL, Larouche J, Badhiwala J, David E, Jerzak KJ, Singnurkar A, Heyn C, Whyne C, Ruschin M, Sahgal A

Nature reviews. Clinical oncology2026

DOI: 10.1038/s41571-026-01152-z PMID: 42086902

Reirradiation outcomes following salvage conventionally fractionated Gamma Knife stereotactic radiotherapy (SFGK) to recurrent primary non-glial brain tumors.

Udovicich C, Tseng CL, Detsky J, Chen H, Dinakaran D, Soliman H, Zeng KL, Ruschin M, Yeboah C, Holden L, Atenafu EG, Sahgal A

Journal of neuro-oncology2026

DOI: 10.1007/s11060-026-05757-3 PMID: 42758433

Evaluation of Organs-at-Risk Sparing for Glioblastoma Patients Using a Small-Margin Weekly Adaptive Protocol on a 1.5T MR-Linac.

Mann T, Stewart J, Safavi AH, Detsky J, Tseng CL, Dinakaran D, Soliman H, Myrehaug S, Chen H, Hudson J, Sahgal A, Ruschin M

International journal of radiation oncology, biology, physics2026Senior author

DOI: 10.1016/j.ijrobp.2026.02.217 PMID: 41720169

Gamma Knife treatment planning using knowledge-based reinforcement learning.

Huynh C, Ahlgren B, Zhang B, Fay D, Nordström H, Ruschin M

Medical physics2026Senior author

DOI: 10.1002/mp.70546 PMID: 42376877

Something wrong or missing on this profile? Suggest a correction

Mark Ruschin

Research

Latest papers

Latest funding

Outcomes following stereotactic body radiation therapy specific to spinal metastases with paraspinal disease extension: does volume matter?

MRI-guided adaptive radiotherapy for high grade glioma (UNITED): a single-centre, single-arm, non-inferiority, phase 2 trial

Impact of Adherence to Target Volume Contouring Guidelines on Patterns of Failure in Sacral Stereotactic Body Radiotherapy

Influence of FLAIR inclusion on patterns-of-failure and outcomes in glioblastoma: results from the UNITED prospective adaptive radiotherapy trial.

First Report of Staged Adaptive Frameless Stereotactic Radiosurgery in 3 "Pulses" to Salvage Brain Metastases that Failed Previous Radiosurgery.

Gamma knife knowledge-based planning with isocenter selection.

The transformative role of SBRT in the management of spinal metastases.

Reirradiation outcomes following salvage conventionally fractionated Gamma Knife stereotactic radiotherapy (SFGK) to recurrent primary non-glial brain tumors.

Evaluation of Organs-at-Risk Sparing for Glioblastoma Patients Using a Small-Margin Weekly Adaptive Protocol on a 1.5T MR-Linac.

Gamma Knife treatment planning using knowledge-based reinforcement learning.

MR-Linac guided adaptive radiotherapy in glioblastoma multiforme

Decision Support System for Stereotactic Radiosurgery

Development of a magnetic resonance imaging and image-analysis framework for high-precision gamma knife-based stereotactic radiosurgery of brain tumours

Frequent collaborators

Arjun Sahgal

Sunit Das

Nir Lipsman

Arman Sarfehnia

Deepak Dinakaran

Daniel Moore Freitas Palhares

Brige Chugh

Chinthaka Heyn

Angus Lau

Victor Yang

Pejman Jabehdar Maralani

David Jaffray

Cari Whyne

Albert Yee

Michael Yan

Greg Stanisz

Jeffrey Greenspoon

Eileen Rakovitch

Chris Bell

Ali Sadeghi-Naini

Caroline Chung

FARHAD Pirouzmand

Lee Chin